Plexium Revenue and Competitors
Estimated Revenue & Valuation
- Plexium's estimated annual revenue is currently $21.5M per year.
- Plexium's estimated revenue per employee is $201,000
- Plexium's total funding is $165M.
Employee Data
- Plexium has 107 Employees.
- Plexium grew their employee count by -3% last year.
Plexium's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Head Technology Development | Reveal Email/Phone |
3 | EVP, Drug Discovery | Reveal Email/Phone |
4 | VP, Biology | Reveal Email/Phone |
5 | Senior Director Proteomics Platform | Reveal Email/Phone |
6 | Director, Biology | Reveal Email/Phone |
7 | Senior Director, Project Management Office | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Director, Software Engineering | Reveal Email/Phone |
10 | Director, Facilities & EHS | Reveal Email/Phone |
Plexium Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Plexium?
Plexium is a pharmaceutical company developing first-in-class therapeutics by modulating E3 ligases
keywords:N/A$165M
Total Funding
107
Number of Employees
$21.5M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Plexium News
(Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced that Plexium President & CEO, Percival Barretto...
In the fall, it backed Avilar Therapeutics and two months ago, it helped pour $102 million into Plexium, the startup headed by Astellas vet...
Plexium Announces $35m Financing to Advance Pipeline of Novel Protein Degraders Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board
Plexium, Inc., a San Diego, CA-based biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, completed a $35M financing. The round was led by Lux Capital and Pivotal BioVentures, with participation from The Col ...
San Diego-based Plexium, a biotech startup focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, announced this morning that it has raised $35M in a financing round. The funding is an extension of the company's October 2019 S ...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.6M | 107 | 7% | $14.3M |
#2 | $12.9M | 107 | 0% | $194.5M |
#3 | $15M | 107 | -3% | $85M |
#4 | $35.1M | 107 | 3% | N/A |
#5 | $28.9M | 107 | 19% | N/A |
